ESC 365 - Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease

EAPC Premium Access

Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease

Session: ePosters

Topic: Secondary Prevention

Speaker: Doctor S. Brennan (Dublin, IE)

Event: ESC Preventive Cardiology 2022

Congress Presentation

Add to my library

About the speaker

Doctor Stephen Brennan

Mater Misericordiae University Hospital, Dublin (Ireland)

0 follower

282 more presentations in this session

Small dense low-density lipoprotein profile in young acute coronary syndrome - a potential risk-stratification tool?

Monitoring pulmonary arterial pressures during cardiac rehabilitation using the CardioMEMS device

Speaker: Miss C. Chaudron (Montpellier, FR)

Comparison of inpatient and outpatient cardiac rehabilitation following myocardial infarction

Speaker: Professor P. Jankowski (Warsaw, PL)

Fas-ligand apoptotic pathway in anthracycline-induced heart failure

Coronary flow reserve in heart failure with preserved left ventricle ejection fraction

Access the full session

ePosters

Speakers: Doctor S. Brennan, Miss C. Chaudron, Professor P. Jankowski

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources